National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

recombinant adenovirus-interferon SCH 721015
A replication-deficient recombinant adenovirus encoding human interferon alpha-2b with potential antineoplastic activity. Upon intravesical administration, recombinant adenovirus-interferon SCH 721015 infects nearby tumor cells and expresses INF alpha-2b intracellularly which activates the transcription and translation of genes whose products mediate antiviral, antiproliferative, antitumor, and immune-modulating effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:rAd-IFN SCH 721015
Code name:SCH 721015

Previous:Rebif, rebimastat, Recentin, recombinant 70-kD heat-shock protein, recombinant adenovirus-hIFN-beta
Next:recombinant adenovirus-L523S vaccine, recombinant adenovirus-p53 SCH-58500, recombinant bispecific single-chain antibody rM28, recombinant CD40-ligand, recombinant dHER2 vaccine